Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EnChroma is a medical technology company that develops advanced spectral filtering lenses designed to enhance color perception for individuals with color vision deficiency (CVD). Founded in 2010 and based in Berkeley, California, the company utilizes proprietary "notch filter" technology to selectively filter out specific wavelengths of light where the overlap between red and green photoreceptors is most problematic. This optical solution allows for a clearer distinction between colors, effectively expanding the range of perceived colors for those with protanomaly and deuteranomaly. EnChroma offers a diverse portfolio of eyewear products for both indoor and outdoor use, including specialized lenses for pediatric and professional applications. The company's mission is to improve the quality of life for the estimated 350 million people worldwide affected by color blindness through innovative optical science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EnChroma.